All Things Angioedema - Learning about Angioedema with Dr Thomas Buttgereit

What comorbidities are seen in people with HAE? Dr Linda Sundler Björkman joins Dr Thomas Buttgereit to discuss her research on comorbidities in HAE, including methodology, key findings, and the need for further research. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/ [https://acare-network.com/]. Additional resources relating to the topics discussed in this episode can be found here: Comorbidities in hereditary angioedema—A population-based cohort study [https://pmc.ncbi.nlm.nih.gov/articles/PMC8967273/]; Increased risk of venous thromboembolism in young and middle-aged individuals with hereditary angioedema: A family study [https://pubmed.ncbi.nlm.nih.gov/38767511/]; Trends in treatments with disease-specific and interfering drugs in patients with hereditary angioedema in Sweden [https://pubmed.ncbi.nlm.nih.gov/36528292/]; and Rare connective tissue diseases in patients with C1-inhibitor deficiency hereditary angioedema: First evidence on prevalence and distribution from a large Italian cohort study [https://pubmed.ncbi.nlm.nih.gov/39493762/].

How do we identify people with non-steroidal anti-inflammatory drug (NSAID)-induced angioedema? Dr Thomas Buttgereit welcomes Dr Stefan Cimbollek to discuss NSAID hypersensitivity in people with angioedema, including clinical manifestations and management strategies. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/ [https://acare-network.com/]. Additional resources relating to the topics discussed in this episode can be found here: An algorithm for the diagnosis and treatment of nonsteroidal anti-inflammatory drugs hypersensitivity, 2024 update [https://onlinelibrary.wiley.com/doi/10.1111/all.16349]; Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. [https://pubmed.ncbi.nlm.nih.gov/26254051/]

What is the emotional, physical, and economical impact of HAE on patient caregivers? Dr Ricardo Zwiener joins Dr Thomas Buttgereit to discuss the significant burden on the “invisible second patients” (caregivers) in HAE and share expert advice on how to extend support to caregivers. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/ [https://acare-network.com/].

How effective are current management approaches for HAE in controlling the disease? HAE patient and physician Kathrin Schön offers her perspective as she joins Dr Thomas Buttgereit to discuss insights from a quality-of-life survey assessing the emotional, physical, and social impact of living with HAE. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/ [https://acare-network.com/].

The Global Angioedema Forum 2024 presented an opportunity to bring together medical specialists, patients, and caregivers from around the world to share their experiences of the management and diagnosis of angioedema. Dr Thomas Buttgereit considers the most poignant discussion points from the event, while Dr Dharmagat Bhattarai summarises some of the challenges he faces working in a clinical setting with limited resources. For more information about the Global Allergy and Asthma Excellence Network - ACARE network and its activities, please visit https://acare-network.com/ [https://acare-network.com/].